<DOC>
	<DOCNO>NCT01750294</DOCNO>
	<brief_summary>It estimate United States approximately 8 million individual moderate severe chronic kidney disease ( CKD ) , dialysis . Volume expansion play important role pathogenesis hypertension patient CKD . For pilot study , investigator hypothesize administration chlorthalidone among patient moderate severe CKD improve blood pressure ( BP ) .</brief_summary>
	<brief_title>A Pilot Study Chlorthalidone Among Patients With Poorly Controlled Hypertension CKD</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<criteria>Age great 18 year . Estimated glomerular filtration rate ( eGFR ) ≤ 45 ml/min/1.73m2 ≥20 mL/min/1.73m2 . Poorly control blood pressure 24hour ambulatory blood pressure ( BP ) monitoring . Treated hypertension : use least one antihypertensive drug . One drug either angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) . If contraindicate use betablocker require . Use thiazide thiazidelike drug previous 3 month . Use furosemide dose &gt; 200 mg/d . Ambulatory BP either ≥160 systolic ≥100 mmHg 24hour ambulatory BP monitoring . Expected receive renal replacement therapy within next 3 month . Vascular event myocardial infarction , heart failure hospitalization , stroke within 3 month prior randomization . Pregnant breastfeed woman woman plan become pregnant use reliable form contraception ( oral contraceptive . condom diaphragms consider reliable ) . Known hypersensitivity thiazide sulfa drug . Organ transplant recipient therapy immunosuppressive agent . Nasal inhale corticosteroid permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>hypertension</keyword>
	<keyword>kidney disease</keyword>
</DOC>